Disclosure Of Entity's Operating Segments [Text Block]

Captor Therapeutics S.A. - Filing #6216905

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
3 986 PLN
Profit (loss) before tax
32 572 PLN
12 694 PLN
Profit (loss) from continuing operations
32 572 PLN
12 694 PLN
Profit (loss)
32 572 PLN
32 572 PLN
32 572 PLN
12 694 PLN
12 694 PLN
12 694 PLN
Assets
143 541 PLN
25 779 PLN
Liabilities
19 340 PLN
26 783 PLN
Cash flows from (used in) operating activities
28 473 PLN
595,000 PLN
Cash flows from (used in) investing activities
5 113 PLN
212,000 PLN
Cash flows from (used in) financing activities
140 875 PLN
881,000 PLN
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.